-
BEAM receives $1.84 million NIH grant to improve preventative screening for opioid use disorder in partnership with UVA Health
September 8, 2023
BEAM Diagnostics, Inc. (BEAM) – a behavioral health company delivering digital assessments to improve patient-centered healthcare – has been awarded a $1.84 million grant from the National Institutes of Health (NIH) to commercialize its pioneering technology, improving and increasing proactive assessment of opioid use disorder in outpatient medical clinics.
-
BEAM announces first alcohol use risk assessments completed by patients in partnership with Carilion Clinic
September 22, 2022
BEAM Diagnostics, Inc. (BEAM) – a behavioral health company delivering digital assessments to improve patient-centered healthcare – announced the first Carilion Clinic patients have completed the Beacon-Alc assessment to improve and increase proactive assessment of alcohol use in outpatient medical clinics.
-
BEAM receives $1.7 million NIH grant to improve preventative screening for alcohol misuse in partnership with Carilion Clinic
April 13, 2022
BEAM Diagnostics, Inc. (BEAM) – a behavioral health company delivering digital assessments to improve patient-centered healthcare – has been awarded a $1.7 million grant from the National Institutes of Health (NIH) to commercialize its pioneering technology dedicated to improving and increasing proactive assessment of alcohol use in outpatient medical clinics.